Worldwide, more than 1.7 billion people are overweight, with a body mass index (BMI) higher than 25, or obese (BMI higher than 30). Additionally, more than 2.5 million deaths are attributed to the consequences of obesity each year.
Previous research has shown that neurotensin (NT) can also stimulate the growth of various cancers and increased fasting levels of pro-NT (an NT precursor hormone) are associated with development of cardiovascular disease and breast cancer. However, a role for NT as a causative factor in these diseases is unknown. NT, a 13 amino acid peptide produced mainly in the gastrointestinal tract and central nervous system, is released with fat ingestion and facilitates fatty acid absorption in the intestine The effects of NT are mediated through three known NT receptors (NTR1, 2 and 3; also known as NTSR1, 2, and NTSR3, respectively).
The study further used animal models to show that a deficiency in NT protects against obesity, insulin resistance and fatty liver disease associated with high fat consumption, thus identifying NT as a potential early marker of future obesity and a novel therapeutic target for this disease.
They further demonstrate that NT attenuates the activation of AMP-activated protein kinase (AMPK) and stimulates fatty acid absorption in mice and in cultured intestinal cells, and that this occurs through a mechanism involving NTR1 and NTR3 (also known as sortilin).
Consistent with the findings in mice, expression of NT in Drosophila midgut enteroendocrine cells results in increased lipid accumulation in the midgut, fat body, and oenocytes (specialized hepatocyte-like cells) and decreased AMPK activation.
The new Nature study also examined data from the Malmö Diet and Cancer Study, a population-based, prospective epidemiologic cohort of 28,449 men and women who were followed for an average of 16.5±1.5 years. The analysis showed that obese and insulin-resistant subjects have significantly elevated levels of fasting pro-NT, and the risk of developing obesity was doubled in non-obese subjects who had fasting pro-NT at the highest concentrations compared to subjects with the lowest concentrations.
These findings directly link NT with increased fat absorption and obesity and suggest that NT may provide a prognostic marker of future obesity and a potential target for prevention and treatment.
Additionally, because NT can contribute to the growth of certain cancers and is now linked with obesity, author speculates that increased NT may contribute to the higher incidence of certain cancers associated with obesity. Building on the findings from this study, future research at the University of Kentucky will examine this possible link.
http://www.nature.com/nature/journal/vaop/ncurrent/full/nature17662.html
New potential marker for obesity
- 2,088 views
- Added
Edited
Latest News
How our cells kill themselves
By newseditor
Posted 27 May
AI predicts the function of…
By newseditor
Posted 27 May
Hippocampo-cortical circuit…
By newseditor
Posted 26 May
A tumor protein p63 isoform…
By newseditor
Posted 24 May
Brain signatures for chroni…
By newseditor
Posted 24 May
Other Top Stories
Evidence for an Age-Dependent Decline in Axon Regeneration in the A…
Read more
Heart failure risk increases with waistline
Read more
Potential new source for pain inhibition
Read more
Higher levels of vitamin D correspond to lower cancer risk
Read more
Mood stabilizer, lithium, increases life span in fruit flies
Read more
Protocols
Designed active-site librar…
By newseditor
Posted 27 May
A microfluidics-enabled aut…
By newseditor
Posted 22 May
TomoTwin: generalized 3D lo…
By newseditor
Posted 17 May
Optimization and validation…
By newseditor
Posted 16 May
EmbryoNet: using deep learn…
By newseditor
Posted 12 May
Publications
Structural basis of NINJ1-m…
By newseditor
Posted 27 May
A general model to predict…
By newseditor
Posted 27 May
Emerging frontiers in regen…
By newseditor
Posted 27 May
Promoting regeneration whil…
By newseditor
Posted 27 May
Massively parallel base edi…
By newseditor
Posted 27 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar